Microbiology

CLSI M39 Webinar

Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data

Gain expert insights into the latest updates in CLSI’s M39 document, Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data. Learn how to optimize antibiograms for more effective antimicrobial stewardship, improve clinical decision-making, and expand applications across various healthcare settings.

What You'll Learn

  • Master the essentials: Key updates from the M39 5th edition and how to implement them in your laboratory.
  • Enhance antimicrobial stewardship: Use antibiograms to guide effective treatment decisions.
  • Think beyond the basics: Discover expanded applications for multifacility, veterinary, and long-term care antibiograms.

Don't miss this opportunity to stay ahead in antimicrobial susceptibility testing!

April 28, 2022

{{FormatPrice(currentPrice)}}

Free

{{FormatPrice(nonMemberPrice)}} List Price
This is your member pricing.
Notify Me About New Editions
Scope

Learning Objectives

At the conclusion of this webinar, the learner will be able to:

  1. List the M39 5th edition recommendations for preparation and use of a routine antibiogram.
  2. Explain the value of antibiograms in antimicrobial stewardship decision making.
  3. Discuss expanded applications of antibiograms to include multifacility, veterinary and LTCF antibiograms.
Speakers
Patricia (Trish) J. Simner, PhD, D(ABMM)
Associate Professor of Pathology and Infectious Diseases, Director of Bacteriology and Infectious Disease Sequencing Laboratories, The Johns Hopkins University School of Medicine, Baltimore, MD
Kate Dzintars, PharmD, BCPS-AQ ID
Clinical Pharmacy Specialist, Infectious Diseases, Associate Pharmacy Director, Antimicrobial Stewardship Program, The Johns Hopkins Hospital, Baltimore, MD
Scope

Learning Objectives

At the conclusion of this webinar, the learner will be able to:

  1. List the M39 5th edition recommendations for preparation and use of a routine antibiogram.
  2. Explain the value of antibiograms in antimicrobial stewardship decision making.
  3. Discuss expanded applications of antibiograms to include multifacility, veterinary and LTCF antibiograms.
Speakers
Patricia (Trish) J. Simner, PhD, D(ABMM)
Associate Professor of Pathology and Infectious Diseases, Director of Bacteriology and Infectious Disease Sequencing Laboratories, The Johns Hopkins University School of Medicine, Baltimore, MD
Kate Dzintars, PharmD, BCPS-AQ ID
Clinical Pharmacy Specialist, Infectious Diseases, Associate Pharmacy Director, Antimicrobial Stewardship Program, The Johns Hopkins Hospital, Baltimore, MD